Una S. Ryan
AS AMERICAN families face the rapidly escalating costs of staying healthy, health care industry experts and politicians each year have brought proposals to the forefront to take pressure off increasing costs. One key milestone for controlling costs was an action taken by Congress in 1984 dramatically changing the generic drug approval process. This legislation, the Hatch-Waxman bill, expanded the number ... (Full article: 654 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
